1Banchereau J, Steinman RM. Dendritic cells and the control of immunity [J]. Nature, 1998, 392:245.
2Steinman RM. The dendritic cell system and its role in immunogenecity [J]. Annu Rev Immu, 1991,9:271.
3Peters JH, Gieseler R,Thiele B, et al.Dendritic cells:from ontogenetic orphans to myelomonocytic descendants [J]. Immunol Today, 1996,17:273.
4Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells [J]. Curr Opin Immunol,1997,9(1):10.
5Fernandez-Ruiz E, Somoza, Sanchez-Madrid F, et al. CD28/CTLA-4 ligands: the gene encoding CD86 (B70/B7.2) maps to the same region as CD80 (B7/B7.1) gene in human chromosome 3q13-q23[J]. Eur J Immunol, 1995, 25(5): 1453.
6Shibusa T, Shijubo N, Abe S.Tumor angiogenesis and vascular endothelial growth factor expression in stage Ⅰ lung adenocarcinoma [J]. Clin Cancer Res, 1998, 4(6): 1483.
7Buggins AGS, Lea N, Gǎken J, et al. Effect of costimulation and the microenvironment on antigen presentation by leukemic cells [J]. Blood,1999,94:3479.
8Rigolin GM, Buggins N, Lea G, et al. Effect of leukemic cells on the differentiation of normal monocyte-derived dendritic cells: a phenotypic and functional analysis [J]. Br J Haematol, 2000, 108(Suppl 1): 35.
9Saraya K, Reid CD. Stem cell factor and regulation of dendritic cell production from CD34+progenitors in bone marrow and cord blood [J]. Br J Haematol, 1996, 93:255.
10Michael D, Roth BJ, Gitlitz, et al. Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients [J]. Cancer Research, 2000, 60:1934.
2Loewenberg B, Downing J R, Burnett A. Acute myeloid leukemia[J]. New Engl J Med, 1999,341 : 1051 -- 1062.
3Hirano N,Takahashi T,Ohtake S,et al. Expression of costimu-latory molecules in human leukemia[J]. Leukemia, 1996, 10:1168--1176.
4Costello R T,Mallet F,Sainty D,et al. Rulation of CD80/B7-1 and CD86/BT-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition[J]. Eur J Immunol, 1998,28 :90-- 103.
5Law C L,Wormann B,Lebien T W. Analysis of expression and function of CD40 on nomal and leukemic human B cell precursors [J]. Leukemia, 1990,4 : 732-- 738.
6Boussiotis V A,Freoman G J,Gribben J G,et al. The critical role of CD28 signaling in the prevention of human T-cell anergy[J]. Res Immunol, 1994,146: 140-149.
7Boussiotis V A, Freoman G J ,Gray G,et al. B7 but not intercelluar adhension molecule costimulation pevents the induction of human alloantigen-specific tolerance[J]. J Exp Med, 1993,178 :175:3-- 1763.
8Gribben J G, Guinnn E L, Boussiotis V A, et al. Complete blockade of B7 family-mediated costimulation is nesessary to induce human alloantigen-specific anergy:a method to ameliorate graft versus-host disease and extend the donor pool[J].Blood, 1996,87 : 4887-- 4893.
9Young J W,Steinman R M. The hematopoietic development of dendritic cell A distinct pathway for myeloid differentiation[J]. Stem Cell, 1996,14 (4): 376- 387.
10Romani N,Gruner S,Brang D,et al. Proliferating dendritic cell progenitors in human blood[J]. J Exp Med, 1994,180 : 83-- 93.
